IBDEI110 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16682,1,3,0)
;;=3^Personal Hx of Malig Neop of Cervix Uteri
;;^UTILITY(U,$J,358.3,16682,1,4,0)
;;=4^Z85.41
;;^UTILITY(U,$J,358.3,16682,2)
;;=^5063418
;;^UTILITY(U,$J,358.3,16683,0)
;;=Z85.43^^61^776^89
;;^UTILITY(U,$J,358.3,16683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16683,1,3,0)
;;=3^Personal Hx of Malig Neop of Ovary
;;^UTILITY(U,$J,358.3,16683,1,4,0)
;;=4^Z85.43
;;^UTILITY(U,$J,358.3,16683,2)
;;=^5063420
;;^UTILITY(U,$J,358.3,16684,0)
;;=Z85.46^^61^776^90
;;^UTILITY(U,$J,358.3,16684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16684,1,3,0)
;;=3^Personal Hx of Malig Neop of Prostate
;;^UTILITY(U,$J,358.3,16684,1,4,0)
;;=4^Z85.46
;;^UTILITY(U,$J,358.3,16684,2)
;;=^5063423
;;^UTILITY(U,$J,358.3,16685,0)
;;=Z85.47^^61^776^94
;;^UTILITY(U,$J,358.3,16685,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16685,1,3,0)
;;=3^Personal Hx of Malig Neop of Testis
;;^UTILITY(U,$J,358.3,16685,1,4,0)
;;=4^Z85.47
;;^UTILITY(U,$J,358.3,16685,2)
;;=^5063424
;;^UTILITY(U,$J,358.3,16686,0)
;;=Z85.51^^61^776^78
;;^UTILITY(U,$J,358.3,16686,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16686,1,3,0)
;;=3^Personal Hx of Malig Neop of Bladder
;;^UTILITY(U,$J,358.3,16686,1,4,0)
;;=4^Z85.51
;;^UTILITY(U,$J,358.3,16686,2)
;;=^5063428
;;^UTILITY(U,$J,358.3,16687,0)
;;=Z85.528^^61^776^83
;;^UTILITY(U,$J,358.3,16687,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16687,1,3,0)
;;=3^Personal Hx of Malig Neop of Kidney
;;^UTILITY(U,$J,358.3,16687,1,4,0)
;;=4^Z85.528
;;^UTILITY(U,$J,358.3,16687,2)
;;=^5063430
;;^UTILITY(U,$J,358.3,16688,0)
;;=Z85.6^^61^776^74
;;^UTILITY(U,$J,358.3,16688,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16688,1,3,0)
;;=3^Personal Hx of Leukemia
;;^UTILITY(U,$J,358.3,16688,1,4,0)
;;=4^Z85.6
;;^UTILITY(U,$J,358.3,16688,2)
;;=^5063434
;;^UTILITY(U,$J,358.3,16689,0)
;;=Z85.72^^61^776^98
;;^UTILITY(U,$J,358.3,16689,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16689,1,3,0)
;;=3^Personal Hx of Non-Hodgkin Lymphomas
;;^UTILITY(U,$J,358.3,16689,1,4,0)
;;=4^Z85.72
;;^UTILITY(U,$J,358.3,16689,2)
;;=^5063436
;;^UTILITY(U,$J,358.3,16690,0)
;;=Z85.79^^61^776^88
;;^UTILITY(U,$J,358.3,16690,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16690,1,3,0)
;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
;;^UTILITY(U,$J,358.3,16690,1,4,0)
;;=4^Z85.79
;;^UTILITY(U,$J,358.3,16690,2)
;;=^5063437
;;^UTILITY(U,$J,358.3,16691,0)
;;=Z85.820^^61^776^77
;;^UTILITY(U,$J,358.3,16691,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16691,1,3,0)
;;=3^Personal Hx of Malig Melanoma of Skin
;;^UTILITY(U,$J,358.3,16691,1,4,0)
;;=4^Z85.820
;;^UTILITY(U,$J,358.3,16691,2)
;;=^5063441
;;^UTILITY(U,$J,358.3,16692,0)
;;=Z85.828^^61^776^92
;;^UTILITY(U,$J,358.3,16692,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16692,1,3,0)
;;=3^Personal Hx of Malig Neop of Skin
;;^UTILITY(U,$J,358.3,16692,1,4,0)
;;=4^Z85.828
;;^UTILITY(U,$J,358.3,16692,2)
;;=^5063443
;;^UTILITY(U,$J,358.3,16693,0)
;;=Z85.71^^61^776^72
;;^UTILITY(U,$J,358.3,16693,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16693,1,3,0)
;;=3^Personal Hx of Hodgkin Lymphoma
;;^UTILITY(U,$J,358.3,16693,1,4,0)
;;=4^Z85.71
;;^UTILITY(U,$J,358.3,16693,2)
;;=^5063435
;;^UTILITY(U,$J,358.3,16694,0)
;;=Z65.8^^61^776^144
;;^UTILITY(U,$J,358.3,16694,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16694,1,3,0)
;;=3^Psychosocial Circumstance Related Problems
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI110 3822 printed Nov 22, 2024@17:09:50 Page 2
IBDEI110 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16682,1,3,0)
+2 ;;=3^Personal Hx of Malig Neop of Cervix Uteri
+3 ;;^UTILITY(U,$J,358.3,16682,1,4,0)
+4 ;;=4^Z85.41
+5 ;;^UTILITY(U,$J,358.3,16682,2)
+6 ;;=^5063418
+7 ;;^UTILITY(U,$J,358.3,16683,0)
+8 ;;=Z85.43^^61^776^89
+9 ;;^UTILITY(U,$J,358.3,16683,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,16683,1,3,0)
+12 ;;=3^Personal Hx of Malig Neop of Ovary
+13 ;;^UTILITY(U,$J,358.3,16683,1,4,0)
+14 ;;=4^Z85.43
+15 ;;^UTILITY(U,$J,358.3,16683,2)
+16 ;;=^5063420
+17 ;;^UTILITY(U,$J,358.3,16684,0)
+18 ;;=Z85.46^^61^776^90
+19 ;;^UTILITY(U,$J,358.3,16684,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,16684,1,3,0)
+22 ;;=3^Personal Hx of Malig Neop of Prostate
+23 ;;^UTILITY(U,$J,358.3,16684,1,4,0)
+24 ;;=4^Z85.46
+25 ;;^UTILITY(U,$J,358.3,16684,2)
+26 ;;=^5063423
+27 ;;^UTILITY(U,$J,358.3,16685,0)
+28 ;;=Z85.47^^61^776^94
+29 ;;^UTILITY(U,$J,358.3,16685,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,16685,1,3,0)
+32 ;;=3^Personal Hx of Malig Neop of Testis
+33 ;;^UTILITY(U,$J,358.3,16685,1,4,0)
+34 ;;=4^Z85.47
+35 ;;^UTILITY(U,$J,358.3,16685,2)
+36 ;;=^5063424
+37 ;;^UTILITY(U,$J,358.3,16686,0)
+38 ;;=Z85.51^^61^776^78
+39 ;;^UTILITY(U,$J,358.3,16686,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,16686,1,3,0)
+42 ;;=3^Personal Hx of Malig Neop of Bladder
+43 ;;^UTILITY(U,$J,358.3,16686,1,4,0)
+44 ;;=4^Z85.51
+45 ;;^UTILITY(U,$J,358.3,16686,2)
+46 ;;=^5063428
+47 ;;^UTILITY(U,$J,358.3,16687,0)
+48 ;;=Z85.528^^61^776^83
+49 ;;^UTILITY(U,$J,358.3,16687,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,16687,1,3,0)
+52 ;;=3^Personal Hx of Malig Neop of Kidney
+53 ;;^UTILITY(U,$J,358.3,16687,1,4,0)
+54 ;;=4^Z85.528
+55 ;;^UTILITY(U,$J,358.3,16687,2)
+56 ;;=^5063430
+57 ;;^UTILITY(U,$J,358.3,16688,0)
+58 ;;=Z85.6^^61^776^74
+59 ;;^UTILITY(U,$J,358.3,16688,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,16688,1,3,0)
+62 ;;=3^Personal Hx of Leukemia
+63 ;;^UTILITY(U,$J,358.3,16688,1,4,0)
+64 ;;=4^Z85.6
+65 ;;^UTILITY(U,$J,358.3,16688,2)
+66 ;;=^5063434
+67 ;;^UTILITY(U,$J,358.3,16689,0)
+68 ;;=Z85.72^^61^776^98
+69 ;;^UTILITY(U,$J,358.3,16689,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,16689,1,3,0)
+72 ;;=3^Personal Hx of Non-Hodgkin Lymphomas
+73 ;;^UTILITY(U,$J,358.3,16689,1,4,0)
+74 ;;=4^Z85.72
+75 ;;^UTILITY(U,$J,358.3,16689,2)
+76 ;;=^5063436
+77 ;;^UTILITY(U,$J,358.3,16690,0)
+78 ;;=Z85.79^^61^776^88
+79 ;;^UTILITY(U,$J,358.3,16690,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,16690,1,3,0)
+82 ;;=3^Personal Hx of Malig Neop of Lymphoid,Hematpoetc & Rel Tissue
+83 ;;^UTILITY(U,$J,358.3,16690,1,4,0)
+84 ;;=4^Z85.79
+85 ;;^UTILITY(U,$J,358.3,16690,2)
+86 ;;=^5063437
+87 ;;^UTILITY(U,$J,358.3,16691,0)
+88 ;;=Z85.820^^61^776^77
+89 ;;^UTILITY(U,$J,358.3,16691,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,16691,1,3,0)
+92 ;;=3^Personal Hx of Malig Melanoma of Skin
+93 ;;^UTILITY(U,$J,358.3,16691,1,4,0)
+94 ;;=4^Z85.820
+95 ;;^UTILITY(U,$J,358.3,16691,2)
+96 ;;=^5063441
+97 ;;^UTILITY(U,$J,358.3,16692,0)
+98 ;;=Z85.828^^61^776^92
+99 ;;^UTILITY(U,$J,358.3,16692,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,16692,1,3,0)
+102 ;;=3^Personal Hx of Malig Neop of Skin
+103 ;;^UTILITY(U,$J,358.3,16692,1,4,0)
+104 ;;=4^Z85.828
+105 ;;^UTILITY(U,$J,358.3,16692,2)
+106 ;;=^5063443
+107 ;;^UTILITY(U,$J,358.3,16693,0)
+108 ;;=Z85.71^^61^776^72
+109 ;;^UTILITY(U,$J,358.3,16693,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,16693,1,3,0)
+112 ;;=3^Personal Hx of Hodgkin Lymphoma
+113 ;;^UTILITY(U,$J,358.3,16693,1,4,0)
+114 ;;=4^Z85.71
+115 ;;^UTILITY(U,$J,358.3,16693,2)
+116 ;;=^5063435
+117 ;;^UTILITY(U,$J,358.3,16694,0)
+118 ;;=Z65.8^^61^776^144
+119 ;;^UTILITY(U,$J,358.3,16694,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,16694,1,3,0)
+122 ;;=3^Psychosocial Circumstance Related Problems
